芬瑞诺在糖尿病治疗中的作用 糖尿病 脏病
Parijat De1, May T Khine1, Andrew Frankel2
1Sandwell & West Birmingham NHS Trust, Birmingham, UK.
BMC nephrology
|February 8, 2025
概括
新的研究突出显示,finerenone是2型糖尿病患者糖尿病病 (DKD) 的有希望的治疗方法. 这种非类固醇药物有效降低血压,并减少DKD进展和心血管风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
背景情况:
- 糖尿病病 (DKD) 是2型糖尿病的一个主要并发症,导致末期功能衰竭.
- 高血压是糖尿病患者DKD进展和心血管疾病的关键可修改风险因素.
- 氨酸抗素阿尔多激素系统 (RAAS) 阻塞是DKD的标准治疗方法,但具有局限性.
研究的目的:
- 审查目前关于芬瑞龙用于管理2型糖尿病的DKD的证据.
- 在英国的背景下提供关于fineerenone使用的建议.
- 评估芬在减少DKD进展和心血管事件中的作用.
主要方法:
- 关于finerenone的当前科学证据的审查.
- 对临床试验数据分析关于finerenone的有效性和安全性.
- 在DKD管理中为fineerenone制定基于共识的指南.
主要成果:
- 芬龙是一种非类固醇选择性矿物质皮质类抗体,可以有效降低血压.
- 芬瑞诺在2型糖尿病中显著降低了DKD进展和心血管事件风险.
- 有证据表明,在DKD的不同阶段,finerenone对DKD的益处有所支持.
结论:
- 菲内伦代表了2型糖尿病中DKD的新兴和有效的治疗选择.
- 有针对性的血压管理和新疗法,如芬瑞,对于减缓DKD进展至关重要.
- 提供了建议,以优化将finerenone纳入英国临床实践,以对DKD进行管理.
相关概念视频
01:11Renal Failure: Dose Adjustments
60
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
60
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
374
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
474
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
474
01:27Dialysis
254
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
254